1. amores51049
2. agngolf
3. TTrade333
4. WillSchibler79
5. suzie954403
1.WillSchibler79 03/26/2018
Presented data from TOPACIO trial of niraparib in combination with anti-PD-1 monoclonal antibody, KEYTRUDA; …
2.TTrade333 05/03/2018
Misses
3.WillSchibler79 02/26/2018
Enters into clinical collaboration with Roche's Genentech
4.TTrade333 06/20/2018
Intereconomia reports that Roche is apparently studying an acquisition of the company
5.suzie954403 08/03/2018
Chart
6.amores51049 01/13/2018
Relevant News: - TESARO Announces Updates to the U.S. Prescribing Information for VARUBI® (rolapitant) Injectable Emulsion
7.wasserleiche 05/04/2018
TESARO Announces First-Quarter 2018 Operating Results
8.amores51049 04/16/2018
TESARO Summarizes TSR-042 Clinical Data Presented at AACR
9.agngolf 02/27/2018
TESARO Announces Collaboration to Evaluate Combination of ZEJULA® (Niraparib) and Anti-PD-L1 Cancer Immunotherapy in Metastatic Bladder Cancer
10.WillSchibler79 10/25/2017
Big news, FDA Approval
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW